Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia

PloS One
Myungwon ChoiCheol E Han

Abstract

Several metrics of analysis of magnetic resonance imaging (MRI) have been used to assess Alzheimer's disease (AD)-related neurodegeneration. We compared four structural brain MRI analysis metrics, cortical thickness, volume, surface area, and local gyrification index (LGI), in different stages of AD-related cognitive decline. Participants with normal cognition, mild cognitive impairment, and AD were included (34 participants per group). All undertook the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery of neuropsychological tests and brain MRI scanning. We analyzed associations between morphometric measures and CERAD total/ Mini Mental State Examination (MMSE) scores for the regions of interest (ROIs), identifying three types of curves: U-shaped, inverted U-shaped, and linear. Cortical thickness and volume analyses showed linear types in most of the significant ROIs. Significant ROIs for the cortical thickness analysis were located in the temporal and limbic lobes, whereas those for volume and surface area were distributed over more diffuse areas of the brain. LGI analysis showed few significant ROIs. CERAD total scores were more sensitive to early changes of cortical structures than MMSE scores. Corti...Continue Reading

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Aug 1, 1988·The Journal of Hospital Infection·J Cohen
Jul 8, 1988·Science·P Rakic
Jul 14, 1998·Nature Medicine·C GeulaB A Yankner
Jan 13, 2000·Archives of General Psychiatry·G BartzokisJ Mintz
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·B Fischl, A M Dale
Feb 24, 2001·Annals of the New York Academy of Sciences·H BraakE Braak
Nov 12, 2002·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Richard N Jones, Joseph J Gallo
Dec 5, 2003·Cerebral Cortex·Bruce FischlAnders M Dale
Mar 31, 2004·Biological Psychiatry·Katherine L NarrArthur W Toga
Jul 13, 2005·Neurology·M J ChandlerC M Cullum
Jan 10, 2006·Cerebral Cortex·Maryam E RettmannSusan M Resnick
Feb 1, 2008·Cerebral Cortex·Kiho ImSun I Kim
Mar 13, 2008·IEEE Transactions on Medical Imaging·Marie SchaerJean-Philippe Thiran
Dec 26, 2008·Neurology·Akram BakkourBradford C Dickerson
Mar 3, 2009·Magnetic Resonance Imaging·John Ashburner
Mar 21, 2009·Cerebral Cortex·Matthew S PanizzonWilliam S Kremen
May 15, 2009·Brain : a Journal of Neurology·Olivier QuerbesUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Sep 25, 2009·Neurobiology of Aging·George Bartzokis
Dec 28, 2010·NeuroImage·Thomas JubaultOury Monchi
Oct 11, 2012·Journal of Alzheimer's Disease : JAD·Latha VelayudhanUNKNOWN dNeuroMed Consortium
Dec 6, 2012·IEEE Transactions on Medical Imaging·Evgeniy LebedMirza Faisal Beg
Jun 21, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andreas B StorsveKristine B Walhovd
Aug 8, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Shuyu LiYing Han

❮ Previous
Next ❯

Software Mentioned

MATLAB
FreeSurfer
Predictive Analytics
linstats

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.